The brain's immune cells removed plaques and helped restore a healthier environment in the brains of immunized patients. For over 30 years, scientists have focused on treating Alzheimer’s disease by ...

Research shows experimental anti-amyloid drug reduced cognitive symptom risk by 50% in people with rare genetic mutations ...

The new findings center on a subset of 22 participants who received amyloid-removing drugs the longest, on average eight ...

A long-term human trial has found that a discontinued drug halved the presentation of early-onset Alzheimer's disease in ...

The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...

Amyloid protein can limit the ability of the ... Waxy-appearing papules may present on the face and neck, the groin, axillae, anal area, tongue, or in ear canals. Edema, purpura (hemorrhage ...

Brain games claim to boost memory, but do they truly work? Learn what actually protects your brain and the best ways to ...

Through Synapticure, patients will be able to use LillyDirect to find in-person Alzheimer’s specialists or to connect with ...

Initially, Amvuttra’s annual list price will be nearly double the yearly cost of rival medicines from Pfizer and BridgeBio.

Alnylam's Amvuttra enters ATTR-CM drug race, and Expedition Therapeutics seeks to bring Chinese drugs to the U.S.

Sex differences in tau may help explain why women face higher Alzheimer's dementia risk than men. At high levels of brain amyloid-beta, women had more aggressive tau accumulation than men ...